When your upstream process is optimized, we can scale into larger bioreactors to provide the amount of product needed from 2L to 500L for a range of modalities. For gene therapy customers only, try our EpyQ® AAV Production System with 2 plasmids instead of 3 to increase quality and lower cost with no impact to scale. And tailor your downstream processing workflows with the option for in-house fill/finish in two of our United States locations.
Let us meet you where your process is at with a global footprint offering GMP manufacturing services & capacity in US and Europe.
57500 sqft
GMP manufacturing facility in Alachua, Florida (US)
57000 sqft
GMP Quality Control (QC) facility in Munich, Germany (EU)
72000 sqft
GMP manufacturing & testing facility in Rockville, Maryland (US)
The Ascend team started from therapeutic development roots with decades of specialty expertise in adeno-associated viral vectors (AAV) for gene therapies in early 2023.
